Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Retina > Local anesthesia more cost-effective than general anesthesia for vitreoretinal surgery
  • Retina

Local anesthesia more cost-effective than general anesthesia for vitreoretinal surgery

Ophthalmology 360

Compared to general anesthesia (GA) for vitreoretinal surgeries, local anesthesia (LA) is more cost-effective and leads to an earlier discharge, according to a poster presented at ASRS 2022.

In this retrospective review, data from 1790 patients who underwent vitreoretinal surgery were analyzed. GA was used in 1107 patients and LA in 683. Vitreoretinal surgery was classified into 3 groups based on surgical: scleral buckle, simple vitrectomy, and complex vitrectomy.

The mean age of patients who received GA was 49.8 years compared with 62.8 years for those who received LA (P < 0.001). In the LA group, 481 patients had >1 comorbidity compared to 390 patients in the LA group. The anesthesia mean (SD) duration was 148.37 (52.76) for GA and 95.56 (95.56) for LA (P < 0.001).

Patients who received LA had a significantly shorter stay in the postoperative anesthesia care unit than those who received GA.

The following predicted the use of GA:
-Young age
-Scleral buckle
-Pars plana vitrectomy for complex retinal detachment

Reference
Chauhan M, et al. Analysis of the Cost-Effectiveness of Local Anesthesia Compared With General Anesthesia for Vitreoretinal Surgery. Presented at: ASRS 2022.

Share

Related Content

  • Retina

Biosimilar aflibercept-ayyh demonstrates favorable real-world safety and efficacy

  • Retina

Switching to aflibercept 8 mg improved anatomical outcomes in previously treated nAMD

Neovascular Age-related Macular Degeneration: Emerging Therapies With an EYE On Treatment Frequency
  • Retina

Treat-and-extend aflibercept 8 mg improves outcomes in nAMD over 1 year

  • Retina

Intravitreal therapy in nAMD linked to lower depression and anxiety risk

  • Retina

Alternative aflibercept regimens maintained efficacy in wet AMD

  • Retina

Nanoscope Therapeutics is working on the potential first-ever optogenetic therapy for retinal diseases

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon